The United States Food and Drug Administration’s staff endorsed the Johnson & Johnson single shot coronavirus vaccine for emergency use authorization on Wednesday following a detailed analysis of the jab.
The FDA’s vaccine advisers are set to meet on Friday to discuss recommending the vaccine for emergency use authorization, after which it is expected the agency will give it the green light promptly.
The vaccine developed by J&J was found to be 72% effective in US clinical trials and 85% effective in preventing severe disease across all regions where it was tested. The vaccine would be the third to be approved for use in the US, following the FDA’s approval of the Pfizer/BioNTech and Moderna jabs.
According to Amer Bahbouha, professor of geography and specialist in meteorology, we will quickly have…
The members of the Security Council expressed their deep concern over reports of the discovery…
The police force this evening burst into the headquarters of the Maison de l'Avocat as…
The public prosecutor's office at the Sousse Court of First Instance has issued Arrest Warrants…
According to Mosaïque FM's sources, journalists Borhène Bsaïes and Mourad Zeghidi are currently being interrogated…
The arrest warrant issued against Sonia Dahmani was executed a short time ago and, according…
This website uses cookies.